Clinical Trials and Preclinical Infrastructure Asset Map - Genome BC
Clinical Trials and Preclinical Infrastructure Asset Map - Genome BC
Clinical Trials and Preclinical Infrastructure Asset Map - Genome BC
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Network Description<br />
Cancer/ Hematology<br />
National<br />
The C17 Council (www.c17.ca) Organization composed of the institutionally appointed heads of the 16 pediatric hematology, oncology, <strong>and</strong> stem<br />
cell transplantation programs in Canada. Acts as an authoritative Canadian voice representing the interests of children<br />
<strong>and</strong> adolescents with cancer <strong>and</strong> blood disorders. CFRI’s Paul Rogers is one of the Council members <strong>and</strong> Co-Chair of the<br />
Cancer Care for Adolescents <strong>and</strong> Young Adults Committee.<br />
CLINICAL TRIALS AND PRECLINICAL INFRASTRUCTURE ASSET MAP<br />
Canadian Blood & Marrow Transplant Group (www.cbmtg.org) National, voluntary, multi-disciplinary organization providing leadership <strong>and</strong> promoting excellence in patient care,<br />
research <strong>and</strong> education in the field of blood <strong>and</strong> marrow transplantation (BMT). CFRI’s Kirk Schultz is a prominent<br />
member.<br />
Canadian Urologic Oncology Group (CUOG) (www.cuog.org) Created, owned <strong>and</strong> operated by its members, CUOG is a clinical research investigator network. The Consortium is a national<br />
alliance of leading academic <strong>and</strong> community based urologists, medical oncologists, <strong>and</strong> radiation oncologists. It is<br />
headquartered in Vancouver. VGH’s Martin Gleave is past Chair of <strong>and</strong> a continuing member of the Executive Committee;<br />
<strong>BC</strong>CA’s Tom Pickles <strong>and</strong> Kim Chi are members of the Executive Committee.<br />
International group sponsored by the US National Cancer Institute that conducts epidemiologic, clinical <strong>and</strong> translational<br />
research in pediatric cancer. CFRI’s Paul Rogers is a prominent member.<br />
The NCIC CTG is funded by the NCIC (now Canadian Cancer Society Research Institute) through its world-renowned peer<br />
review process. A number of B.C. investigators are on various NCIC CTG Executive Committees. <strong>BC</strong>CA’s Kim Chi is on the<br />
Genitourinary (GU) Disease Site Executive Committee; Chair of the sub-site Advanced Prostate group; <strong>and</strong> Executive<br />
Committee Member <strong>and</strong> Chair-elect of the Investigational New Drug Site; Stephen Chia is on the <strong>Clinical</strong> <strong>Trials</strong> Committee<br />
<strong>and</strong> Breast Site Executive Committee; Hagan Kennecke is on the GI Executive Committee; Christopher Lee is on the<br />
Lung Site Executive Committee; Martin Gleave is past Chair of <strong>and</strong> continues to be a member of the GU <strong>Clinical</strong> <strong>Trials</strong><br />
Group Executive Committee.<br />
Children’s Oncology Group (COG) (www.childrensoncologygroup.org)<br />
National Cancer Institute of Canada <strong>Clinical</strong> <strong>Trials</strong> Group (NCIC<br />
CTG) (www.cancer.ca/research/)<br />
International network of Australian <strong>and</strong> Canadians who can coordinate their skills <strong>and</strong> solve the complex problems facing<br />
prostate cancer. The Vancouver Prostate Centre is the Canadian Hub of this alliance <strong>and</strong> a founding member.<br />
The <strong>Clinical</strong> <strong>Trials</strong> Cooperative Group Program, sponsored by the National Cancer Institute (NCI), promotes <strong>and</strong> supports<br />
clinical trials of new cancer treatments, explores methods of cancer prevention <strong>and</strong> early detection, <strong>and</strong> studies qualityof-life<br />
issues <strong>and</strong> rehabilitation during <strong>and</strong> after treatment. Cooperative groups include researchers, cancer centres, <strong>and</strong><br />
community physicians throughout the U.S, Canada, <strong>and</strong> Europe. A number of B.C. investigators are on NCI Executive<br />
Committees. <strong>BC</strong>CA’s Kim Chi is on the Prostate Cancer Task Force Committee; Hagan Kennecke is on the Neuroendocrine<br />
International<br />
Australian-Canadian Prostate Cancer Research Alliance (www.<br />
aus-canprostatealliance.org)<br />
National Cancer Institute (U.S.)-Canada <strong>Clinical</strong> <strong>Trials</strong> Group<br />
(www.cancer.gov/cancertopics/factsheet/NCI/clinical-trialscooperative-group)<br />
285<br />
Task Force Committee.<br />
CFRI’s Kirk Schultz is past Chair.. A voluntary group of clinicians <strong>and</strong> scientists that includes over 100 pediatric PBMTC<br />
centres in North America, Australia <strong>and</strong> New Zeal<strong>and</strong>. Purpose is to engage in scientific <strong>and</strong> educational activities<br />
related to the use of hematopoietic stem cells in the treatment of diseases of children <strong>and</strong> adolescents.<br />
Pediatric Bone <strong>and</strong> Marrow Transplant Consortium (PBMTC)<br />
(www.pbmtc.org)